| Speech Therapy Solutions, Llc | |
|
47 W Railroad St, Stanton, KY 40380-2034 | |
| (606) 663-8008 | |
| (606) 663-0550 |
| Full Name | Speech Therapy Solutions, Llc |
|---|---|
| Type | Facility |
| Speciality | Speech-language Pathologist |
| Location | 47 W Railroad St, Stanton, Kentucky |
| Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1952539215 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 3433 (Kentucky) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Speech Therapy Solutions, Llc 47 W Railroad St, Stanton, KY 40380-2034 Ph: (606) 663-8008 | Speech Therapy Solutions, Llc 47 W Railroad St, Stanton, KY 40380-2034 Ph: (606) 663-8008 |
News Archive
To enhance service offerings throughout Europe, Quintiles Transnational Corp. today announced the opening of an expanded regional facility near Edinburgh, Scotland. The purpose-built facility consolidates three buildings into a single state-of-the-art complex.
The defective gene responsible for Friedreich's ataxia was identified over 20 years ago, but so far our ideas of how this gene causes the disease have been merely speculative. It was assumed that, as a result of the mutation, the gene could no longer be transcribed because this stretch of DNA was inaccessible. FMI Group Leader Marc Bühler and his team have now carried out experiments demonstrating that this is not the case and revealing what actually happens in Friedreich's ataxia.
A study co-authored by Dr. Michael A. Lindsey, Executive Director of the McSilver Institute for Poverty Policy & Research at the Silver of Social Work at New York University, has found that transgender people who are denied access to mental health treatment experience a higher risk of substance abuse and attempted suicide.
Adamas Pharmaceuticals, Inc., a privately held company, announced today that a multi-center in vitro study of its proprietary triple combination antiviral drug (TCAD) therapy showed substantially greater potency against seasonal and novel H1N1 influenza viruses than currently recommended single or double therapy and that the triple combination is active against drug-resistant flu strains.
› Verified 6 days ago
Courtney Alexis Bowling, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 31 Derickson Ln, Stanton, KY 40380 Phone: 606-663-0435 | |
Rebecka Laura Belcher, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 31 Derickson Ln, Stanton, KY 40380 Phone: 606-663-0435 Fax: 606-663-8040 | |
Linda S Abner, CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 440 Washington St, Stanton, KY 40380 Phone: 606-663-5771 Fax: 606-663-5650 | |
Charlene Nicole Skeens, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 31 Derickson Ln, Stanton, KY 40380 Phone: 606-663-0435 |